We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Filters applied:

Search Results

Showing 1-20 of 1,697 results
  1. L-carnitine and Acetyl-L Carnitine: A Possibility for Treating Alterations Induced by Obesity in the Central Nervous System

    Excessive consumption of nutrients, as well as obesity, leads to an inflammatory process, especially in adipose tissue. This inflammation reaches the...

    Larissa Espindola da Silva, Mariana Pacheco de Oliveira, ... Gislaine Tezza Rezin in Neurochemical Research
    Article 27 July 2023
  2. The Effect of Acetyl-L-Carnitine (ALCAR) on Peripheral Nerve Regeneration in Animal Models: A Systematic Review

    Peripheral neuropathies caused by the peripheral nervous system (PNS) damage can occur due to trauma and other disorders. They present as altered...

    Sara Pourshahidi, Ahmad Reza Shamshiri, ... Mahdi Ghorbani in Neurochemical Research
    Article 11 April 2023
  3. Acetyl-L-Carnitine Exerts Neuroprotective and Anticonvulsant Effect in Kainate Murine Model of Temporal Lobe Epilepsy

    The most well-known type of focal epilepsy that is resistant to existing treatments is temporal lobe epilepsy (TLE), with seizure foci in various...

    Mahsa Tashakori-Miyanroudi, Samira Ramazi, ... Mehrdad Roghani in Journal of Molecular Neuroscience
    Article 23 March 2022
  4. Acetyl-L-carnitine confers neuroprotection against lipopolysaccharide (LPS) -induced neuroinflammation by targeting TLR4/NFκB, autophagy, inflammation and oxidative stress

    Acetyl-L-carnitine has been shown to exert neuroprotection against neurodegenerative diseases. The present study was performed to evaluate...

    Nida Jamali-Raeufy, Fahimeh Alizadeh, ... Mina Goudarzi in Metabolic Brain Disease
    Article 12 March 2021
  5. Use of Acetyl-L-Carnitine in Gerontological Practice

    Published data on the efficacy and safety of using acetyl-L-carnitine (ALC) in gerontological practice are analyzed and the spectrum of biochemical...

    Article 26 April 2019
  6. Correction to: Acetyl-L-carnitine confers neuroprotection against lipopolysaccharide (LPS) -induced neuroinflammation by targeting TLR4/NFκB, autophagy, inflammation and oxidative stress

    A Correction to this paper has been published: 10.1007/s11011-021-00721-8

    Nida Jamali-Raeufy, Fahimeh Alizadeh, ... Mina Goudarzi in Metabolic Brain Disease
    Article 31 March 2021
  7. Antioxidant supplementation may effect DNA methylation patterns, apoptosis, and ROS levels in developing mouse embryos

    This study was designed to address the question: does antioxidant-containing embryo culture media affect DNA methyltransferases, global DNA...

    Fatma Uysal, Gozde Sukur, ... Ozgur Cinar in Histochemistry and Cell Biology
    Article Open access 17 April 2024
  8. Acetyl-L-Carnitine downregulates invasion (CXCR4/CXCL12, MMP-9) and angiogenesis (VEGF, CXCL8) pathways in prostate cancer cells: rationale for prevention and interception strategies

    Background

    Prostate cancer (PCa) is a leading cause of cancer-related death in males worldwide. Exacerbated inflammation and angiogenesis have been...

    Denisa Baci, Antonino Bruno, ... Douglas M. Noonan in Journal of Experimental & Clinical Cancer Research
    Article Open access 12 November 2019
  9. Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial

    Background

    Alzheimer’s disease (AD) is associated with metabolic abnormalities linked to critical elements of neurodegeneration. We recently...

    Burak Yulug, Ozlem Altay, ... Adil Mardinoglu in Translational Neurodegeneration
    Article Open access 26 January 2023
  10. Effect of Acetyl-l-carnitine Used for Protection of Neonatal Hypoxic-Ischemic Brain Injury on Acute Kidney Changes in Male and Female Rats

    Neonatal hypoxia-ischemia (HI) is a common cause of brain injury in infants. Acute kidney injury frequently occurs after birth asphyxia and is...

    Andrew G. Wang, Michele Diamond, ... Mary C. McKenna in Neurochemical Research
    Article 30 April 2019
  11. Mechanistic perspectives on differential mitochondrial-based neuroprotective effects of several carnitine forms in Alzheimer’s disease in vitro model

    Mitochondrial deregulation has emerged as one of the earliest pathological events in Alzheimer’s disease (AD), the most common age-related...

    Sandra I. Mota, Inês Pita, ... A. Cristina Rego in Archives of Toxicology
    Article 24 June 2021
  12. Screening Methods for the Evaluation of Hepatoprotective Agents

    Liver being the major site of metabolism of xenobiotics, it is predisposed to the harmful effects of the toxic metabolites generated during...
    Jayapriya Balamurugan, Lourdu Jafrin in Introduction to Basics of Pharmacology and Toxicology
    Chapter 2022
  13. Pharmacological Treatment of Established Chemotherapy-Induced Peripheral Neuropathy

    Pharmacological treatment of chemotherapy-induced peripheral neuropathy (CIPN) is still in its infancy and available options are limited. Both...
    Chapter 2021
  14. BCAA metabolism in pancreatic cancer affects lipid balance by regulating fatty acid import into mitochondria

    Background

    Pancreatic ductal adenocarcinoma (PDAC) has been associated with the host dysmetabolism of branched-chain amino acids (BCAAs), however, the...

    Klára Gotvaldová, Jitka Špačková, ... Katarína Smolková in Cancer & Metabolism
    Article Open access 26 March 2024
  15. Screening of melatonin, α-tocopherol, folic acid, acetyl-l-carnitine and resveratrol for anti-dengue 2 virus activity

    Objective

    Infections with the mosquito transmitted dengue virus (DENV) are a significant public health burden in many parts of the world. Despite the...

    Atchara Paemanee, Atitaya Hitakarun, ... Duncan R. Smith in BMC Research Notes
    Article Open access 16 May 2018
  16. Metabolic Approaches to the Treatment of Autism Spectrum Disorders

    Children with autism spectrum disorder (ASD) may exhibit metabolic abnormalities, either with or without an underlying inherited metabolic...
    Neluwa-Liyanage R. Indika, Susan C. Owens, ... Richard E. Frye in Neurobiology of Autism Spectrum Disorders
    Chapter 2023
  17. Fluoride impairs vascular smooth muscle A7R5 cell lines via disrupting amino acids metabolism

    Given the insidious and high-fatality nature of cardiovascular diseases (CVDs), the emergence of fluoride as a newly identified risk factor demands...

    Yan-Shu Li, Ru-Ru Yang, ... Bing-Yun Li in Journal of Translational Medicine
    Article Open access 01 June 2024
  18. Anomalies of Energy Metabolism in Schizophrenia and Possible Pathogenetically Targeted Therapeutic Approaches

    Abstract —Coordinated regulation of energy conversion processes in the brain maintains its highly productive work and efficient mental activity....

    I. S. Boksha, T. A. Prokhorova, ... G. Sh. Burbaeva in Neurochemical Journal
    Article 01 December 2023
  19. Clinical Application and Trials with Nutraceuticals

    Pharmaceutical drugs are chemical compounds that are designed to prevent, diagnose, and treat a specific disorder. Nutraceuticals are products that...
    Jonathan Newell, Jayakumar Nithura, ... Hussain Hussain in Nutraceuticals for Alzheimer's Disease: A Promising Therapeutic Approach
    Chapter 2023
  20. Altered acylcarnitine metabolism and inflexible mitochondrial fuel utilization characterize the loss of neonatal myocardial regeneration capacity

    Myocardial regeneration capacity declines during the first week after birth, and this decline is linked to adaptation to oxidative metabolism....

    E. Kankuri, P. Finckenberg, ... E. Mervaala in Experimental & Molecular Medicine
    Article Open access 03 April 2023
Did you find what you were looking for? Share feedback.